RxDoctor Payments DataLook up a doctor →

Bernard Buchanan, PhD

Internal Medicine · Owensboro, KYNPI 1881623395

Payments from drug & device makers

$224,102in general payments, 2019–2025

Across 816 payments — averaging $274.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$82K
  • Novo Nordisk$46K
  • Boehringer Ingelheim$29K
  • Radius Health, Inc.$21K
  • AstraZeneca$13K
  • AbbVie$11K
  • plus $23K from 48 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Amgen(2 entities)193$81,716
Novo Nordisk135$46,154
Boehringer Ingelheim59$29,226
Radius Health, Inc.17$20,750
AstraZeneca(2 entities)33$12,990
AbbVie(2 entities)55$10,760
Amarin Pharma, Inc.82$9,331
Lilly USA, LLC34$5,544
GE HealthCare1$2,892
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC14$1,183
Insulet Corporation16$364
Corcept Therapeutics18$267
Johnson & Johnson18$247
Shield Therapeutics Inc8$242
Medtronic10$218
Xeris Pharmaceuticals, Inc.9$180
Novartis13$180
Mannkind Corporation11$179
Abbott12$162
Galderma Laboratories, L.p.1$150
Astellas Pharma US Inc6$146
Sanofi-aventis U.S. LLC7$105
Bayer6$95
Dexcom, Inc.6$86
Biosense Webster, Inc.1$84
Tandem Diabetes Care, Inc.3$65
Phathom Pharmaceuticals, Inc.3$60
Esperion Therapeutics, Inc.4$58
Merck4$53
GSK3$50
Antares Pharma, Inc.3$48
Sumitomo Pharma America, Inc.3$48
Pfizer3$40
Teva Pharmaceuticals USA, Inc.2$36
Echosens North America, Inc.1$32
Nevro Corp.2$32
Regeneron Healthcare Solutions, Inc.2$25
BETA Bionics, Inc.1$24
Ultragenyx Pharmaceutical Inc.1$23
Ascensia Diabetes Care US Inc.1$23
Kowa Pharmaceuticals America, Inc.2$22
Qiagen, LLC1$20
Madrigal Pharmaceuticals1$19
Amryt Pharma Holdings Ltd1$19
Sanofi Pasteur Inc.1$19
Sequel Med Tech, LLC1$19
Ironwood Pharmaceuticals, Inc1$18
Vanda Pharmaceuticals Inc.1$16
Lifescan, Inc.1$15
Shire North American Group Inc1$14
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)1$14
Recordati_rare_diseases_inc.1$14
Dermira, Inc.1$12
Endogastric Solutions, Inc1$12

How this compares

$224,102 in reported general payments places this provider in the 95th percentile of 1,284 internal medicine providers in Kentucky.

See all internal medicine providers in Kentucky →

Medicare billing

Part B allowed, 2024
$1,033,196
Medicare patients
1,635
Services billed
112,525

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in Owensboro

See the full list for Kentucky →

Where these figures come from

Is this you, or does something look wrong? →